Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education(EACCME) and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:
Michael M. Alper Declared to be member of a company advisory board: Emd Serono.
Maria Bustillo Declared to be member of the board of director: Advanced Reproductive Care and to participate in a company sponsored speaker’s bureau: Serono.
Frank Chang Declared no potential conflict of interest.
Paul Devroey Declared to receive grants from: Ferring, Merck-Serono, Shering-Plough, Avecova.
Robert Fischer Declared receipt of honoraria or consulations fees from Serono Symposia International Foundation and to be member of the Scientific Committee of Serono Symposia International Foundation.
Victor Y. Fujimoto Declared to be member of a medical advisory board: Emd Serono, Ferring.
He Feng Huang Declared no potential conflict of interest.
Jean Noël Hugues Declared to receive grants from: Merck-Serono.
Peter Humaidan Declared no potential conflict of interest.
Richard Legro Declared to receive NIH grants various and consultation fee by Solvay and Merck-Serono.
Milton Leong Declared no potential conflict of interest.
Shin Yong Moon Declared no potential conflict of interest.
Santiago Munnè Declared to be stakeholder in Reprogenetics company.
Jie Qiao Declared no potential conflict of interest.
The following faculty have provided no information regarding significant relationship with commercial supporters and/or discussion of investigational or non-EMEA/FDA approved (off-label) uses of drugs as of November 9, 2009:
Timur Gurgan
